CEP152 Antikörper (AA 810-890)
Kurzübersicht für CEP152 Antikörper (AA 810-890) (ABIN7220602)
Target
Alle CEP152 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 810-890
-
Verwendungszweck
- CEP152 Polyclonal Antibody
-
Spezifität
- CEP152 Polyclonal Antibody detects endogenous levels of CEP152 protein.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
-
Immunogen
- Synthesized peptide derived from the Internal region of human CEP152 at AA range: 810-890
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), IHC-P (1:100-1:300), ELISA (1:40000). Not yet tested in other applications.
-
Kommentare
-
Primary Antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- CEP152 (Centrosomal Protein 152kDa (CEP152))
-
Andere Bezeichnung
- CEP152
-
Hintergrund
- Rabbit Anti-CEP152 Polyclonal Antibody,CEP152, KIAA0912, Centrosomal protein of 152 kDa, Cep152,CEP152 encodes a protein that is thought to be involved with centrosome function. Mutations in this gene have been associated with primary microcephaly (MCPH4). Alternative splicing results in multiple transcript variants.,Centrosomal protein of 152 kDa
-
Molekulargewicht
- observerd band 140kDa
-
Gen-ID
- 22995
-
UniProt
- O94986
-
Pathways
- M Phase
Target
-